Opus Medical Therapies Honored with Most Fundable Company Award

SMYRNA, Ga. - Sept. 29, 2023 - PRLog -- Opus Medical Therapies, a pioneering medical technology company specializing in the development of innovative cardiac interventions, is thrilled to announce that it has been recognized as one of the finalists in the Most Fundable Companies competition held by Pepperdine Graziadio Business School. Out of over 3,000 early-stage companies that vied for this prestigious award, Opus Medical Therapies stood out as one of the 17 outstanding winners.

The Most Fundable Companies program, hosted by Pepperdine Graziadio Business School, is an esteemed national competition designed to identify and celebrate high-potential startups with groundbreaking technologies, visionary leadership, and exceptional growth prospects. This recognition underscores Opus Medical Therapies' commitment to revolutionizing cardiac care with its groundbreaking transseptal transcatheter mitral valve replacement (TMVR) device and proprietary anchoring platform.

"Opus Medical Therapies' TMVR device represents a significant leap forward in the treatment of mitral valve disease, a condition that affects millions of individuals worldwide. The company's innovative solution promises to enhance patient outcomes, reduce procedure complexity, and minimize recovery times," said Dr. Vivek Rajagopal, CMO and Founder of Opus Medical Therapies.

"Recognition as a Most Fundable Company from Pepperdine Graziadio Business School is a tremendous honor and a testament to the dedication and expertise of our entire team at Opus Medical Therapies," said Jaime Sarabia, CEO at Opus Medical Therapies. "Our mission is to provide innovative and effective solutions for patients suffering from heart valve disease. This recognition reinforces our belief that we are on the right path to making a profound impact in the structural heart field."

For more information, please visit http://www.opus-medical.com or https://bschool.pepperdine.edu/events/most-fundable-compa...